CancerNetwork® spoke with Phillip Low, PhD, about the development and FDA approval of pafolacianine.
Approval Alert | Pafolacianine for Ovarian Cancer Detection During Surgery
Pafolacianine for Ovarian Cancer Detection During Surgery
Videos
Articles
Philip S. Low, PhD, discusses the obstacles he overcame while creating pafolacianine and what other cancers he hopes will be improved with the use of this agent.
Imaging drug pafolacianine was approved by the FDA to detect ovarian cancer lesions in patients during surgery.
Advertisement
Advertisement
Trending on CancerNetwork
1
Daraxonrasib/Vopimetostat Yields Stunning Response Rate in MTAP-del Pancreatic Cancer
2
Blinatumomab Substitution Improves EFS in Pediatric High-Risk B-ALL
3
Atezolizumab/Chemo Earns FDA Priority Review in Stage III dMMR/MSI-H Colon Cancer
4
Talquetamab Plus Daratumumab Improves PFS in Relapsed/Refractory Myeloma
5